Background/Objectives: Unlike most Western populations, MTHFR 677T is a rare allele and a risk factor for a variety of disorders in India. What kind of nutritional (environmental) and/or genetic factors could contribute to the genetic risk is not known. To assess the incidence of hyperhomocysteinemia and its correlation with the polymorphism in homocysteine (Hcy)-pathway genes and associated cofactors in the native populations of eastern India. Subjects/Methods: Healthy population from four eastern states of India. Genotyping of SNPs, HPLC and chemiluminescencebased assay for homocysteine, vitamin B12 and folic acid.
Introduction
Homocysteine (Hcy) is a precursor of methionine and cysteine. Methionine converts into S-adenosyl methionine, which acts as a universal methyl donor (Selhub, 1999) . These multi-step reactions involve various enzymes and cofactors in the form of essential micronutrients, which include vitamin B complex family (B2, B6, B9 and B12). Although vitamin B12 and B6 are the cofactors, respectively, in Hcy to methionine and cysteine conversions, folate is important as the substrate for 5-methyl THF. More than 15 mmol/l of Hcy in blood is clinically hyperhomocysteinemia (Maron and Loscalzo, 2009 ). This condition, arising mostly due to deficiency in the cofactor vitamins along with genotype of the individual, is considered as a risk factor in various disease conditions, such as neural tube defects, cardio-vascular disorders and neuronal disorders (Refsum et al., 2004; Reynolds, 2006; Harshman and Aldoori, 2008; Selhub, 2008; Li et al., 2009; Greene et al., 2009) . A better regime of B12 and folic acid is often helpful to counter the levels of hyperhomocysteinemia (hypHcy) (Bronstrup et al., 1998; Kluijtmans et al., 2003; Konstantinova et al., 2007) . A genetic predisposition to Hcy level is indicated by the fact that individuals having mutation/polymorphism in the Hcy metabolism pathway genes (for example, MTHFR), that lower the enzyme activity, tend to have elevated levels of Hcy (Carmel et al., 2003) . However, the frequency of different genotypes varies considerably among populations (Gueant-Rodriguez et al., 2006) . Gene polymorphisms impacting Hcy metabolism impair amino-acid metabolism, methylation and nucleotide biosynthesis. Hence, singlenucleotide polymorphism (SNPs) in Hcy-pathway genes act as markers of disease predisposition in case-control and population studies.
The T allele of the SNP C677T of MTHFR, especially in homozygous condition, is associated with hypHcy, and is a risk factor for several disorders (James et al., 1999; Selhub, 2008; Coppede, 2009) . MTHFR, A1298C, is also a risk factor in these disorders though to a lesser degree (Martinez-Frias et al., 2006) . However, in normal populations the frequency of T homozygosity of C677T, swings from 1% (Africa, Southeast Asia) to around 30% (Europe, Americas), suggesting that the SNPs have different selective potential in different populations (Rosenberg et al., 2002; GueantRodriguez et al., 2006; Zee et al., 2007) . In populations having high T allele frequency (X20%), the Hcy level tends to be independent of the genotype (Gueant-Rodriguez et al., 2006; Yang et al., 2008) . One of the reasons of the ineffectiveness of 677TT homozygotes as a risk factor in Europe and American populations is suspected to be due to non-vegetarian diet that supplements vitamin B6 and 12, and fortification of food with folic acid (McLean et al., 2008; Elmadfa and Singer, 2009) .
Case-control studies in our laboratory in populations from eastern regions of India show MTHFR SNPs, especially 677TT homozygosity, as a risk factor for male infertility , Down syndrome (Rai et al., 2006) and non-syndromic cleft lip ± palate (Ali et al., 2009 ). The C variant in MTHFR A1298C is also a risk factor though at a relatively low level. Most importantly, TT homozygous 'normal' mothers show genetic predisposition towards Down syndrome and nonsyndromic cleft lip ± palate affected children (Rai et al., 2006; Ali et al., 2009) . In several other populations T homozygosity of 677T shows no bearing on these disorders.
The present study is an attempt to understand genotypephenotype relationship between Hcy and Hcy-pathway genes under varied nutritional conditions in the 'normal, healthy' populations from Eastern Indian states.
Subjects and methodology

Subjects
As in our earlier case-control studies, vast majority of patients came from regions east/southeast of Varanasi from the states of Uttar Pradesh, Bihar, Jharkhand and Chhattisgarh, the present survey was confined to the same regions ( Figure 1 ) on 1426 (820 males; 606 females) healthy subjects with the median age 35 years (B95% rural). A questionnaire regarding food habits (consumption frequency of milk, pulses, green leafy vegetables, fruits, egg and non-veg), medical history (hypertension, diabetics, cardiovascular, renal and gastro-intestinal) and B complex supplementation was taken along with the written consent of the subject. The study was approved by Ethical committee of Institute of Medical Sciences, Banaras Hindu University.
Collection of blood
Peripheral blood (5 ml ) was collected into EDTA coated vials. Plasma was collected from 1 ml of blood and stored at À80 1C until analysed for metabolites. Blood (1.5 ml) was used for hematological analysis. DNA was extracted from rest of the blood. It was ensured that the blood plasma for Hcy, vitamin B12 and folic acid analyses was separated on site, and brought to the lab within 20 h of the collection.
Metabolite and vitamins assay
Hcy was assayed by reverse phase HPLC using a fluorescence detector (Shimadzu, Kyoto, Japan) (Kumar et al., 2005) . Vitamin B12 and folic acid were assayed by Chemiluminescence competitive immunoassay (Immunolite 1000 Analyser, SIEMENS Diagnostic Products, Flanders, NJ, USA) as per the manufacturer's instructions.
Quality control
Reproducibility of biochemical measurements was ensured by performing measurements of Hcy, vitamin B12 and folic acid on instruments in different laboratories (IGIB, New Delhi and King Edwards Memorial Hospital, Pune). Vitamin B12 and folic acid were initially measured by radioimmunoassay and microbial assay and later predominantly by chemiluminescence. Measurements of 40 samples were compared with IGIB Delhi and 100 (including the 40 measured in Delhi) with Pune. There was o5% deviation in the results (data not shown). The genotyping was repeated twice randomly for 20% of analysed samples, which yielded 100% identical results.
Genetic analysis
Using gene-specific primers, DNA was PCR-amplified and restriction digested with specific enzymes, and examined for RFLPs of MTHFR (C677T & A1298C), CBS (844ins68 bp), MTR (A2756G) and RFC1 (G80A) (Chango et al., 2000; Dutta et al., 2005; Rai et al., 2006; Barbosa et al., 2008) . The SNPs and the 68 bp insertion of CBS were resolved, respectively, on 3.5 and 2% agarose gels. 
Statistical analysis
Results
Total Hcy in blood plasma and genetic profile were analysed in 1426 individuals (males-820, females-606), while vitamin B12 and folic acid were measured in 1290 individuals (745 males and 545 females) from the same cohort. Genetically there was no significant region-specific difference in the five markers and they were all in HardyWeinberg equilibrium, indicating their genetic homogeneity (Table 1) . However, there was diversity in Hcy, vitamin B12 and folic acid levels among regions (Table 2) . Collectively, 28% of the population had hypHcy (415 mmol/l), and 49% was deficient in vitamin B12 and 11% in folic acid.
Hcy, vitamin B12 and folic acid levels The median of Hcy in different regions ranged between 10.7 and 13.1 mmol/l, collective median being 12.1 mmol/l. Hcy level in males was consistently higher than in females (Table 2) , more strikingly in cases of hypHcy. Compared with non-vegetarians, hypHcy was significantly higher in vegetarians, and in non-vegetarian females it was even lower, showing a gender and dietary bias towards hypHcy (data not shown), as earlier documented (Alfthan et al., 2003; Elmadfa and Singer, 2009) .
Median of B12 ranged between 199 and 255 pg/ml and of folic acid between 4.4 and 5.3 ng/ml, B8% being deficient in both. As expected, vitamin B12 level was higher in nonvegetarians, even in those consuming it once a week, than in vegetarians. No such correlation existed with folic acid. Of those deficient in both vitamin B12 and folic acid, 63% had hypHcy. In contrast, only 11% of those having optimum levels of both showed hypHcy. Incidence of hypHcy in individuals with only B12 or only folic acid deficiency was, respectively, 41% and 22%. In subjects with both vitamin B12 and folic acid deficiency, the relative risk for hypHcy was eight times greater than those with optimum level of both (Table 3) .
Genotype of the Hcy-pathway genes Genotype of CBS was the most homogeneous with only one insertion homozygote (allele frequency 0.03). In RFC1 G80A, GA heterozygotes comprised 47.2% of the population, and homozygotes GG and AA, 33.7% and 19.1%, respectively. The frequency of minor alleles in MTR A2756G was 0.29 and in MTHFR A1298C was 0.28. In C677T MTHFR the frequency of T allele was 0.12 and TT homozygosity only 2.1%.
MTR and CBS genotypes did not show association with Hcy levels (B12 mmol/l). Another study on CBS and Hcy from a north Indian cohort had shown similar pattern (Kumar et al., 2010) . In MTHFR C677T, A1298C and RFC1 G80A, the Hcy level varied with the genotype. There was a slight increase in Hcy with MTHFR 1298C and RFC1 80G, but with MTHFR 677T it increased sharply (Table 4 ). The relative risk for hypHcy with 677TT was 35.50 vis-a-vis CC and CT genotypes of that gene. RFC1 80A lowered Hcy level. When genotypes of individual alleles of all the three genes were combined, each SNP contributed to Hcy level differently; addition of every single mutant allele of MTHFR and G allele of RFC1 raised the mean Hcy level, whereas the A allele of 
Abbreviation: SNP, single-nucleotide polymorphism. RFC1 lowered its level even with T allele (Table 4) . However, in mutant genotypes (677T, 1298A) with optimal vitamin B12 (4220 pg/ml) Hcy level was lower than in the mutants with low B12 levels ( Table 5 ). There was a moderate modulation of folic acid when taken in association with B12 deficiency, whereas folic acid deficiency alone had minimal effect on Hcy level (Tables 3 and 5) . MTHFR 677TT/1298CC was not found in any combination (Table 4) .
Discussion
The World Bank (2009) estimates of India in the year 2009 show that nearly 50% population would suffer from acute malnutrition causing high child mortality, many communicable diseases and hematological disorders. The report also says that 47% of Indian children are malnourished for both macro-and micro-nutrients. The region of India where the present study was conducted is health-impoverished even by Indian standards. Our previous case-control studies from the same region have shown rather low frequency of MTHFRC677T and A1298C in the control samples, but association as a risk factor with male infertility, cleft lip/palate and Down syndrome Rai et al., 2006; Ali et al., 2009) . Therefore, in measuring tHcy, folic acid and vitamin B12, vis-à-vis the genotypes of the Hcy-pathway genes, our objective is to evaluate contribution of the individual variables (SNPs of Hcy-pathway genes) in the development of the phenotype (Hcy level), and to get an estimate of the relative contribution of environment (vitamins) in modulating the effect of genotypes in this region. 0.013 MTHFR AA1298 (n) (n ¼ 52) 15.9 (12.5-20.8) (n ¼ 282) 13.4 (10.9-16.2) (n ¼ 16) 10.1 (7.8-14.2) (n ¼ 323) 8.9 (6.3-12.1) o0.0001 MTHFR AC1298 (n) (n ¼ 39) 16.9 (11.7-19.9) (n ¼ 205) 14.6 (11.2-17.9) (n ¼ 23) 12.3 (8.3-15.6) (n ¼ 243) 10.8 (8.1-13.2) 0.0018 MTHFR CC1298 (n) (n ¼ 7) 17. 2 (11.8-20.8) (n ¼ 47) 15.4 (12.1-19.5) (n ¼ 6) 11.4 (9.3-12.8) (n ¼ 47) 12.2 (9.3-14.4) 0.0021 RFC1 GG80 (n) ( n ¼ 27) 16.5 (10.1-20.0) (n ¼ 189) 14.2 (10.8-17.9) (n ¼ 16) 10.9 (7.9-15.1) (n ¼ 199) 10.0 (7.4-13.2) o0.0001 RFC1 GA80 (n) ( n ¼ 56) 16.9 (11.8-20.8) (n ¼ 260) 14.5 (11.6-17.8) (n ¼ 21) 11.2 (8.4-14.5) (n ¼ 278) 10.5 (7.8-13.4) o0.0001 RFC1 AA80 (n) ( n ¼ 15) 15.6 (12.5-17.2) (n ¼ 85) 11.8 (9.6-15.1) (n ¼ 8) 11.8 (6.7-14.8) (n ¼ 136) 8.6 (6.1-11.1) o0.0001
Abbreviations: ANOVA, analysis of variance; Hcy, homocysteine; IQR, interquartile range. Vit. B12 and folic acid levels (n ¼ 1290). Group 1 ¼ o220 pg/ml of B12 þ o3 ng/ml folic acid, Group 2 ¼ o220 pg/ml of B12 þ X3 ng/ml folic acid. Group 3 ¼ X220 pg/ml of B12 þ o3 ng/ml folic acid, Group 4 ¼ X220 pg/ml of B12 þ X3 ng/ml folic acid.
Genotypically, of the five polymorphisms examined only three, MTHFR C677T, A1298C and RFC1 G80A SNPs, affect Hcy level in this population. Significantly, the two MTHFR mutant homozygotes (TTCC) never occur together, which appears to be the situation globally, as large scale studies by Fredriksen et al. (2007) in Norway and a meta-analysis by Martinez-frias (2008) also fail to get this combination. It is reasonable to conclude that this genotypic combination is under strong selection pressure (also see Callejon et al., 2007) . In this population, only 30 individuals (2.1%) are TT homozygous, and there is hardly a TT individual whose Hcy level is less than 15 mmol/l regardless of the combination of other genes. All the three individuals with TT/AC/GA have individually 35.6, 62.7 and 84.2 mmol/l Hcy levels. Notwithstanding their low number, the trend is clear that in this population T homozygosity of the codon 677 alone is enough to cause hyperhomocysteinemia. This study also shows a close genotype-phenotype relationship with each mutant allele contributing additively to Hcy levels ( Table 4) .
The lowest Hcy level (8.9 mmol/l) with wild-type MTHFR alleles, 677CC/1298AA, was found in combination with RFC1 80AA. This effect of RFC1 AA allele even with the mutant MTHFR SNPs confirms that it contributes to the lowering of Hcy level, as earlier reported (Chango et al., 2000; Yates and Lucock, 2005; Dufficy et al., 2006) . However, the protection is seen only with AA genotype not with GA. Interestingly, the cause of protection against the disease is assumed to be better cellular intake of folates rather than lowering of Hcy (Yates and Lucock, 2005) . Paradoxically, there are also reports that suggest that RFC1 80AA, at least marginally, impairs the RBC folate levels (Dufficy et al., 2006) . In our population, we find no significant difference in folate levels corresponding to RFC1 genotypes, rather the B12 deficiency is significantly less in individuals with AA genotype (data not shown). Therefore, at present it is unclear why it should have an influence on Hcy levels differently from the G allele, even in presence of MTHFR SNPs. It is also intriguing that despite being a protective genotype, frequency of RFC1 80AA is lower than GG and GA genotypes. In African-Americans and Hispanics AA is the major allele, though in Caucasians and Ashkenazi Jews it is low (Rady et al., 2001) . Considering that GA heterozygosity is heterotic in the studied population, 'A' allele appears to be recent introduction in this region with AA homozygote having a pleiotropic impact on other metabolic functions.
Hcy-modulation and micronutrients
In most of the European and North American 'healthy' populations Hcy level remains within normal range (8-10 mmol/l), even in MTHFR C677T homozygotes. A plausible explanation is the high incidence of non-vegetarianism and compulsory fortification of diet with folic acid. In India, such fortifications are not done by the state, and dietary conditions are largely vegetarian. Even among those listed as non-vegetarian nearly 70% consume it less than once in a month. On the other hand, leafy vegetables are consumed by the majority of population (data not shown). This dietary regimen at least partly explains the magnitude of vit B12 deficiency (49%), and the lower incidence of folic acid deficiency (11%) in this population. More or less the same scenario is observed in different regions and populations in India (Refsum et al., 2001; Yajnik et al., 2006; Taneja et al., 2007; Kumar et al., 2009a, b) . It is important to note that even Western and South-East Asian populations do not show such high incidence of vitamin B12 deficiency as seen in Indian populations (Gamble et al., 2005; McLean et al., 2008; Elmadfa and Singer, 2009; Thuesen et al., 2010; Waskiewicz et al., 2010) . We further show that out of 613 individuals having optimum vitamin B12, as well as folic acid, only 11% (63) have hypHcy. However, of those having optimum vitamin B12 but low folate level, 22% (10/45) have hypHcy as against 41% (222/533) of those having low vitamin B12 and optimum folate (Table 3) . These results buttress the point that in the population under consideration, deficiency of vitamin B12 is not only prevalent but clinically more crucial than folic acid, and also that the incidence of B12 deficiency in Indian adult population is much greater than in most other populations (see Thuesen et al., 2010) .
When seen in the context of genotypes, it is also noteworthy that in the individuals having optimum vitamin and optimum Hcy levels (n ¼ 613), frequency of the T allele of 677T (MTHFR) is only B10%. In contrast, among those having hypHcy despite optimum vitamin levels (n ¼ 62), T allele frequency is 27%. Obviously, both the genotype and vitamin B12 and folic acid individually affect Hcy to different degrees. And this affect is exacerbated when the genotype is accompanied by B12 and folic acid deficiency. These results are comparable to the massive Norwegian study (Hustad et al., 2007) , as well as one from north India on cardio-vascular patients (Kumar et al., 2009a, b) , that shows strong association of T allele with elevated levels of Hcy and its modulation by vitamin B12.
Curiously, relative to vitamin B12, folic acid deficiency is not only less frequent (45/1290), but appears to be less effective in causing hypHcy in this population (10/45) (group 3 in Table 5 ). Though the physiological reason of it is not intuitively obvious to us, it is noteworthy that the frequency of T allele (MTHFR C677T) in all 45 individuals is around 0.1, including those with hypHcy. In all others (groups 1, 2, 4 in Table 5 ), T allele in hypHcy group is 40.25, and o0.1 in the rest (data not given). That is, unlike others, there is little genotypic contribution in causing hypHcy in group 3; it is majorly due to folic acid deficiency, implying that the contribution of folate deficiency to hypHcy is greater than it appears. Small sample size of this category, especially lack of 677T allele, could well be indicative of the poor selective potential of this combination. It is also intriguing that SNP in MTR gene, which requires vitamin B12 as a cofactor in conversion of Hcy to methionine is neutral in effect even with vitamin B12 deficiency (data not shown). It is plausible that low MTHFR activity and low vitamin B12 together impair both production of 5 Met-THF (low substrate) and methionine (low cofactor), leading to hypHcy. It appears that in the studied population, low micronutrients (especially vitamin B12 B50%) are the most widespread factor to cause elevated Hcy. Also, the scale at which B12 and folate deficiency is prevalent explains why the T allele might be associated with various disorders in Indian population, but not in Western counterparts.
This paper is not a status report on public health in the region. Nevertheless, there is compelling reason to evaluate levels of the micronutrients in the population at large, and employ measures as per individual needs to achieve better community health.
